NIH-funded research R01 grant

Reducing iron levels to improve diabetes and liver health

Official title: Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease

Funded at Wake Forest University Health Sciences · NIH-10761794 · Data updated 2026-11-12

This study is looking at how high iron levels in the body might be linked to type 2 diabetes and fatty liver disease, and it will see if lowering iron through a simple blood donation can help improve blood sugar and liver health for people with too much iron.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWake Forest University Health Sciences
NIH-funded
Lab location1 site (Winston-Salem, United States)
Project startJanuary 20, 2019
Project endDecember 31, 2025
Funding year2024
Award (this year)$658,658
NIH project number5R01DK119913-05
Project IDNIH-10761794 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults with type 2 diabetes and elevated serum ferritin levels.

Less likely to help

Patients with normal iron levels or those who do not have type 2 diabetes or fatty liver disease may not benefit from this research.

What this research studies

This research investigates the relationship between tissue iron levels and the risk of type 2 diabetes and nonalcoholic fatty liver disease. It explores how reducing iron through a procedure called phlebotomy may improve blood sugar levels and liver health in individuals with higher-than-normal iron levels. The study builds on previous findings that suggest a connection between iron overload and these conditions, aiming to clarify the benefits of iron reduction in a human population. Participants will be monitored for changes in their glycemic control and liver function as iron levels are adjusted.

Why it matters

Potential benefit: If successful, this research could lead to new treatment options for patients with type 2 diabetes and fatty liver disease by utilizing iron reduction as a therapeutic strategy.

How similar studies have gone: Previous studies have shown promising results in animal models and pilot trials in humans, indicating that reducing iron may improve diabetes management.

Where this research is happening

  • Wake Forest University Health Sciences
    Winston-Salem, United States
    Active

Researchers

  • Principal investigator: Mcclain, Donald a. — Wake Forest University Health Sciences
  • Study coordinator: Mcclain, Donald a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.